Our results showed that 7c and olaparib exerted synergistic growth inhibition in Molm-13 and MV4-11 cells (Figure 5) and that 7c could sensitize FLT3-ITD+AML cells to PARP inhibition. The gene discussed is PARP1; the disease is acute myeloid leukemia.